{"Patient ID": 0.0, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Affection Status\\Disease status of participant\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\% of FVC predicted at diagnosis PFT\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\% of FVC predicted at most recent PFT\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Annual FEV1 change between PFTs\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Annual FVC change between PFTs\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\Change in FEV1/FVC ratio between diagnosis PFT and recent PFT (minimum 2 year interval)\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\FEV1/FVC ratio of PFT closest to diagnisis\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Laboratory Measurements\\FEV1/FVC ratio of most recent PFT\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Age at recording of phenotypes\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Bone and joint involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Bone marrow involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Cardiac involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Certainty of diagnosis\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chest x-ray at diagnosis recode\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chest x-ray at diagnosis\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Chronic phenotype yes/no\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Extrathoracic lymph gland involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Eye involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Involvement of the liver, non-thoracic lymph glands or bone marrow\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Liver involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Neuro involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Non-thoracic_involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Pulmonary phenotype severity score\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Radiographic resolution on repeat chest x-ray recode\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Radiographic resolution on repeat chest x-ray\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Renal involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Resolution of sarcoid pulmonary involvement based on cxr (minimum 2 year fu)\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Skin involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Spleen involvement\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Upper respiratory tract involvement including the sinuses\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Physical Observatioins\\Worst CXR during follow-up\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sample Attributes\\TOPMed Phase\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Pedigree\\Sex\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Sociodemography\\Gender of participant\\": NaN, "\\NHLBI TOPMed: African American Sarcoidosis Genetics Resource\\Sociodemography and Administration\\Subject IDs and Consents\\Consent group as determined by DAC\\": NaN, "\\_Consents\\Short Study Accession with Consent Code\\": 0.0}